Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often emphasize the possibility for meaningful therapeutic gains, principally in conditions where conventional medications have proven limited. However, crucially important to assess the substantial financial expenditure associated with CPI